Bladder sphincter dyssynergia (also known as detrusor sphincter dyssynergia (DSD) (the ICS standard terminology agreed 1998)[1] and neurogenic detrusor overactivity (NDO)) is a consequence of a neurological pathology such as
spinal injury[2] or
multiple sclerosis[3] which disrupts
central nervous system regulation of the
micturition (urination) reflex resulting in dyscoordination of the
detrusor muscles of the bladder and the
male or
female external urethral sphincter muscles. In normal lower urinary tract function, these two separate muscle structures act in synergistic coordination. But in this neurogenic disorder, the urethral sphincter muscle, instead of relaxing completely during voiding, dyssynergically contracts causing the flow to be interrupted and the bladder pressure to rise.[4]
Presentation
People with this condition generally experience daytime and night time wetting, urinary retention, and often have a history of
urinary tract and bladder infections.
Constipation and
encopresis are often associated with this condition.[citation needed]Pseudodyssynergia has different causes but presents similarly.
Pathology
The pathophysiology of the condition results from neuronal plasticity associated with bladder afferents and
motor neurons innervating the external urethral sphincter.[citation needed]
Treatment
Botulinum A toxin is a valuable alternative for patients who do not want surgical methods.[5]
References
^Stöhrer M, Goepel M, Kondo A, Kramer G, Madersbacher H, Millard R, Rossier A, Wyndaele JJ (1999). "The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee". Neurourology and Urodynamics. 18 (2): 139–58.
doi:
10.1002/(SICI)1520-6777(1999)18:2<139::AID-NAU9>3.0.CO;2-U.
PMID10081953.
S2CID2592963.
^Karsenty G, Reitz A, Wefer B, Boy S, Schurch B (October 2005). "Understanding detrusor sphincter dyssynergia--significance of chronology". Urology. 66 (4): 763–8.
doi:
10.1016/j.urology.2005.04.061.
PMID16230135.
^Stankovich EI, Borisov VV, Demina TL (2004). "[Tamsulosin in the treatment of detrusor-sphincter dyssynergia of the urinary bladder in patients with multiple sclerosis]". Urologiia (4): 48–51.
PMID15457955. Urination disorders occur in 80% patients with multiple sclerosis (MS). The most common of them is detrusor-sphincter dyssynergia (DSD),
^Corcos J, Schick E (2004). Textbook of the neurogenic bladder: adults and children. Informa Health Care. pp. 163–168.
ISBN978-1-84184-206-6.